Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan-Reference-Cited by-同舟云学术

Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan

Published:2013-11 Issue: Volume:64 Page:23-32
ISSN:0882-4010
Container-title:Microbial Pathogenesis
language:en
Short-container-title:Microbial Pathogenesis

Author:

Hausner Marius,Schamberger Anna,Naumann Wolfgang,Jacobs Enno,Dumke Roger

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference45 articles.

1. Mycoplasma pneumoniae and its role as a human pathogen;Waites;Clin Microbiol Rev,2004

2. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections;Atkinson;FEMS Microbiol Rev,2008

3. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ);von Baum;BMC Infect Dis,2009

4. Central nervous system manifestations of Mycoplasma pneumoniae infections;Tsiodras;J Infect,2005

5. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012;Zhao;Antimicrob Agents Chemother,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the pathogenetic mechanisms of Mycoplasma pneumoniae (Review);Experimental and Therapeutic Medicine;2024-04-30

2. Green synthesised CuNPs using Alhagi maurorum extract and its ability to amelioration of Mycoplasma pneumoniae infected pneumonia mice model;Journal of Experimental Nanoscience;2022-09-28

3. Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives;Frontiers in Cellular and Infection Microbiology;2022-05-13

4. An immunoinformatics-based designed multi-epitope candidate vaccine (mpme-VAC/STV-1) against Mycoplasma pneumoniae;Computers in Biology and Medicine;2022-03

5. Vaccine using community-acquired respiratory distress syndrome toxin as an antigen against Mycoplasma pneumoniae in mice;Biochemical and Biophysical Research Communications;2022-02